BioSpace News Archive

Ocutrx Technologies, a California-based technology company known for its ORLenz™ surgery augmented reality headset, and the OR-Bot Surgery Visualization Theatre™, has announced that they are expanding from external visualization augmented reality and extended reality techniques to a first-of-class laparoscopic visualization key-hole instrument called “Scopetrx™”, a Wireless Laparoscopic Swivel Camera Tool.

New research found that weight loss after diagnosis was associated with worse outcomes for HER2-positive early breast cancer patients

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced changes to the Company’s Board of Directors. Garry Neil, MD, has been appointed Chair of the Board. Additionally, Nawal Ouzren has been appointed as a new Board member.

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it appointed Ms. Brenda Castrodad to lead its Human Resources department.

Ecolab Fourth Quarter Reported Diluted Continuing Operations EPS $1.04; Adjusted Diluted Continuing Operations EPS $1.23, -15%; Earnings Show Sequential Improvement From Third Quarter

A survey commissioned by Itamar Medical found that a third of respondents were unaware that treating sleep apnea can significantly reduce the health risks associated with cardiovascular disease, diabetes, and stroke

With ZEISS Visioner 1, ZEISS is launching an innovative digital microscope that for the first time enables all-in-one focus in real time thanks to its Micro-mirror Array Lens System (MALS™).

Dr. Richard Rosenfield’s Pearl Surgicenter embraces Value Based Healthcare, providing reduced cost, high valued surgery to women in the Portland Metropolitan Service area and beyond.

AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has received approval from the required Ethics Committee in the Netherlands to commence its Phase 1 clinical study on the safety of AIM’s drug Ampligen as an intranasal therapy, a critical step in the company’s ongoing efforts to develop Ampligen as a potential prophylaxis or treatment for COVID-19 and other respiratory viral diseases.

SquareWorks Consulting, a leading provider of NetSuite Consulting Services and NetSuite Solutions, is announcing the launch of Biotech-focused NetSuite implementation services.